日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of life

VITACORA-19 和 PsAID 问卷在评估银屑病关节炎对患者生活质量的影响方面具有相同的有效性。

Braña, Ignacio; Loredo, Marta; Torre-Alonso, Juan Carlos; Queiro, Rubén

Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature

欧洲强直性脊柱炎患者患者报告结局:文献系统综述

Torre-Alonso, Juan Carlos; Queiro, Rubén; Comellas, Marta; Lizán, Luís; Blanch, Carles

Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate

预测英夫利昔单抗治疗对甲氨蝶呤耐药的银屑病关节炎的主要临床反应(ACR50)

Gratacós, J; Casado, E; Real, J; Torre-Alonso, J C

Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations

KIR3DL1/3DS1 对人类白细胞抗原-B27 高加索人群中强直性脊柱炎的贡献

Carlos Lopez-Larrea, Miguel Angel Blanco-Gelaz, Juan Carlos Torre-Alonso, Jacome Bruges Armas, Beatriz Suarez-Alvarez, Laura Pruneda, Ana Rita Couto, Segundo Gonzalez, Antonio Lopez-Vázquez, Jesus Martinez-Borra

A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

多关节受累是银屑病关节炎侵蚀性和畸形性疾病的预兆

Queiro-Silva, R; Torre-Alonso, J C; Tinturé-Eguren, T; López-Lagunas, I

Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study

英夫利昔单抗治疗难治性脊柱关节病:一项为期 38 周的多中心开放性研究

Collantes-Estévez, E; Muñoz-Villanueva, M C; Cañete-Crespillo, J D; Sanmartí-Sala, R; Gratacós-Masmitjá, J; Zarco-Montejo, P; Torre-Alonso, J C; González-Fernández, C

Annexin V autoantibodies in rheumatoid arthritis

类风湿性关节炎中的膜联蛋白V自身抗体

Rodríguez-García, M I; Fernández, J A; Rodríguez, A; Fernández, M P; Gutierrez, C; Torre-Alonso, J C

HLA antigens in psoriatic arthritis subtypes of a Spanish population

西班牙人群银屑病关节炎亚型中的HLA抗原

López-Larrea, C; Torre Alonso, J C; Rodriguez Perez, A; Coto, E